LDL-C Management with Evolocumab in ACS Patients -It’s Time to Act!

Organized by CVRF and Supported by Educational Grant from Amgen Korea

Friday, November 26

11:35 AM ~ 12:36 PM * Korea Standard Time (UTC/GMT +9:00)

LDL-C Lowering Strategies for ACS Patients: How Early is Early? Lecturer: Yong-Hoon Yoon

‘Higher Risk, Higher Benefit’ Strategy with Evolocumab in Post-MI Patients Lecturer: Youngwoo Jang

My Clinical Experiences of Evolocumab in ACS Patients Lecturer: Wonjae Lee

Panel Discussion